NOTICE -- Login operations are currently offline due to an unscheduled disruption. We are waiting for LDAP services to be re-instated. We apologize for the inconvenience - June 24, 2021
Yuki Oya
Last active: 10/27/2015

  1. Living donor liver transplantation from a heterozygous parent for classical maple syrup urine disease. Kadohisa M, Matsumoto S, Sawada H, Honda M, Murokawa T, Hayashida S, Ohya Y, Lee KJ, Yamamoto H, Mitsubuchi H, Endo F, Inomata Y (2015) Pediatr Transplant 19(3): E66-9
    › Primary publication · 25708273 (PubMed)
  2. Specific activin receptor-like kinase 3 inhibitors enhance liver regeneration. Tsugawa D, Oya Y, Masuzaki R, Ray K, Engers DW, Dib M, Do N, Kuramitsu K, Ho K, Frist A, Yu PB, Bloch KD, Lindsley CW, Hopkins CR, Hong CC, Karp SJ (2014) J Pharmacol Exp Ther 351(3): 549-58
    › Primary publication · 25271257 (PubMed) · PMC4244585 (PubMed Central)
  3. Single-center experience and long-term outcomes of duct-to-duct biliary reconstruction in infantile living donor liver transplantation. Yamamoto H, Hayashida S, Asonuma K, Honda M, Suda H, Murokawa T, Ohya Y, Lee KJ, Takeichi T, Inomata Y (2014) Liver Transpl 20(3): 347-54
    › Primary publication · 24415519 (PubMed)
  4. Generation of familial amyloidotic polyneuropathy-specific induced pluripotent stem cells. Isono K, Jono H, Ohya Y, Shiraki N, Yamazoe T, Sugasaki A, Era T, Fusaki N, Tasaki M, Ueda M, Shinriki S, Inomata Y, Kume S, Ando Y (2014) Stem Cell Res 12(2): 574-83
    › Primary publication · 24531302 (PubMed)
  5. False tacrolimus concentrations measured by antibody-conjugated magnetic immunoassay in liver transplant patient: 2 case reports and literature review. Taguchi K, Ohmura T, Ohya Y, Horio M, Furukawa K, Jono H, Inomata Y, Saito H (2014) Exp Clin Transplant 12(5): 474-8
    › Primary publication · 24206050 (PubMed)
  6. Changes in pathological and biochemical findings of systemic tissue sites in familial amyloid polyneuropathy more than 10 years after liver transplantation. Oshima T, Kawahara S, Ueda M, Kawakami Y, Tanaka R, Okazaki T, Misumi Y, Obayashi K, Yamashita T, Ohya Y, Ihse E, Shinriki S, Tasaki M, Jono H, Asonuma K, Inomata Y, Westermark P, Ando Y (2014) J Neurol Neurosurg Psychiatry 85(7): 740-6
    › Primary publication · 24023270 (PubMed)
  7. UW solution improved with high anti-apoptotic activity by S-nitrosated human serum albumin. Ishima Y, Shinagawa T, Yoneshige S, Kragh-Hansen U, Ohya Y, Inomata Y, Kai T, Otagiri M, Maruyama T (2013) Nitric Oxide : 36-42
    › Primary publication · 23402724 (PubMed)
  8. Re-evaluation of the indications for liver transplantation in Wilson's disease based on the outcomes of patients referred to a transplant center. Ohya Y, Okajima H, Honda M, Hayashida S, Suda H, Matsumoto S, Lee KJ, Yamamoto H, Takeichi T, Mitsubuchi H, Asonuma K, Endo F, Inomata Y (2013) Pediatr Transplant 17(4): 369-73
    › Primary publication · 23692600 (PubMed)
  9. Peritransplant gastrointestinal symptoms in familial amyloidotic polyneuropathy. Ohya Y, Isono K, Obayashi K, Hayashida S, Lee KJ, Yamamoto H, Takeichi T, Asonuma K, Ando Y, Inomata Y (2013) Exp Clin Transplant 11(4): 327-31
    › Primary publication · 23432183 (PubMed)
  10. Liver transplant from an ABO-incompatible and hepatitis C antibody-positive but an HCV-RNA negative living donor in a familial amyloid polyneuropathy patient. Takeichi T, Asonuma K, Yamamoto H, Ohya Y, Okumura K, Lee KJ, Inomata Y (2013) Exp Clin Transplant 11(2): 182-5
    › Primary publication · 23194392 (PubMed)